【24h】

Oridonin: A promising cell death-inducing anticancer drug from China

机译:冬凌草甲素:来自中国的一种有前途的诱导细胞死亡的抗癌药

获取原文
获取原文并翻译 | 示例

摘要

Oridonin, an ent-kaurene diterpenoid compound isolated from the leaves of Rabdosia rubescens (Hemsl. )Hara, has been used as an anti-inflammatory, antibacterial and anticancer agent in local folk medicine since ancient time. It has been widely recognized as a promising anticancer drug since 1970s. This review is concerned about the mechanisms underlying its anticancer activity. Oridonin induced tumor cell death through apoptosis, necrosis and autophagy without overt toxicity and side effects. Further endeavor to modify the structure of oridonin in order to improve its solubility and activity is worthwhile. Meanwhile, exploration on oridonin with other chemotherapeutics in cancer therapy is also a hot subject of the research.
机译:冬凌草甲素(Oridonin)是一种从天竺葵(Rabdosia rubescens,Hemsl。)Hara的叶子中分离出的一种新的天竺葵双萜类化合物,自古以来就已被用作当地民间医学的消炎,抗菌和抗癌剂。自1970年代以来,它已被广泛认为是一种有前途的抗癌药。这项审查是有关其抗癌活性的潜在机制。冬凌草甲素通过凋亡,坏死和自噬诱导肿瘤细胞死亡,而没有明显的毒性和副作用。值得进一步努力改变冬凌草甲素的结构以提高其溶解度和活性。同时,用冬凌草甲素和其他化学疗法进行癌症治疗也是该研究的热点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号